Co-mutations of TP53 and KRAS serve as potential biomarkers...

BMC Medical Genomics 2019 / 12 Vol. 12; Iss. 1

Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report

Fang, Cheng, Zhang, Chu, Zhao, Wei-Qing, Hu, Wen-Wei, Wu, Jun, Ji, Mei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Journal:
BMC Medical Genomics
DOI:
10.1186/s12920-019-0592-6
Date:
December, 2019
File:
PDF, 2.10 MB
2019
Conversion to is in progress
Conversion to is failed